- 全部删除
- 您的购物车当前为空
KRM-III 是一种具有口服活性的 T 细胞抗原受体 (TCR) 抑制剂,具有抗炎活性,可有效抑制 TCR 和肉豆蔻酸乙酸酯/佛波霉素/离子霉素诱导的 NFAT 核因子活化和 T 细胞增殖,IC50 约为 5 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
KRM-III 是一种具有口服活性的 T 细胞抗原受体 (TCR) 抑制剂,具有抗炎活性,可有效抑制 TCR 和肉豆蔻酸乙酸酯/佛波霉素/离子霉素诱导的 NFAT 核因子活化和 T 细胞增殖,IC50 约为 5 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 209 | In stock | |
5 mg | ¥ 517 | In stock | |
10 mg | ¥ 826 | In stock | |
25 mg | ¥ 1,390 | In stock | |
50 mg | ¥ 2,030 | In stock | |
100 mg | ¥ 2,910 | In stock | |
200 mg | ¥ 3,930 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 559 | In stock |
产品描述 | KRM-III is an orally active T cell antigen receptor (TCR) inhibitor with anti-inflammatory activity that potently inhibits TCR and myristate acetate/fosfomycin/ionomycin-induced NFAT nuclear factor activation and T cell proliferation, with an IC50 of approximately 5 μM. |
靶点活性 | Proliferation (T-cells):~5 μM |
分子量 | 252.33 |
分子式 | C15H12N2S |
CAS No. | 79220-94-3 |
Smiles | S=c1[nH]c(cn1-c1ccccc1)-c1ccccc1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 25.23 mg/mL (100 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容